주식/증권
📈 긍정적
관련 뉴스
Latigo Biotherapeutics, Inc. GAAP EPS of -$0.55 beats by $0.12
2026/11/05
Albertsons ordered to pay $900M in opioid crisis case
2026/11/05
Middleby outlines 2026 guidance raise to $7.13-$7.29 EPS as CEO transition set for April 1, 2027
2026/11/05
Korro Bio GAAP EPS of -$0.98 beats by $0.38
2026/11/05